NIH supports multidisciplinary development or adaptation of non-invasive or minimally invasive technologies for high-resolution imaging of the living human peripheral and central olfactory system.
Funder: National Institutes of Health
Due Dates: August 21, 2026 (Applications) | August 21, 2027 (Applications) | August 21, 2028 (Applications)
Funding Amounts: Up to $500,000 in direct costs annually for up to 5 years; $2 million estimated program funding
Summary: Supports transformative non-invasive or minimally invasive imaging technologies for visualizing the living human olfactory system across scales.
Key Information: Foreign organizations, non-U.S. components of U.S. organizations, and foreign components are not eligible.
The National Institute on Deafness and Other Communication Disorders (NIDCD), with the National Institute of Biomedical Imaging and Bioengineering (NIBIB), supports development, adaptation, and preclinical testing of transformative imaging technologies through this R01 opportunity. Projects must advance non-invasive or minimally invasive visualization of human olfactory targets, from the nasal epithelium to the olfactory bulb, with previously unattainable resolution or specificity.
Relevant approaches include fluorescence probes, specialized endoscopes, optical and acoustic imaging, molecular imaging, and advanced MRI methods. The program seeks tools that distinguish peripheral from central causes of smell disorders, improve diagnosis and potential treatment, and support early identification of neurodegenerative disease. Multidisciplinary teams should combine expertise in olfaction, biomedical imaging, biochemistry, bioengineering, and biophysics, as appropriate. Clinical trials are optional, but only low-risk trials will be funded.